Integrating research and development: the emergence of rational drug design in the pharmaceutical industry
Graduate studies at Western
Studies in History and Philosophy of Science Part C 36 (3):513-537 (2005)
|Abstract||Rational drug design is a method for developing new pharmaceuticals that typically involves the elucidation of fundamental physiological mechanisms. It thus combines the quest for a scientific understanding of natural phenomena with the design of useful technology and hence integrates epistemic and practical aims of research and development. Case studies of the rational design of the cardiovascular drugs propranolol, captopril and losartan provide insights into characteristics and conditions of this integration. Rational drug design became possible in the 1950s when theoretical knowledge of drug-target interaction and experimental drug testing could interlock in cycles of mutual advancement. The integration does not, however, diminish the importance of basic research for pharmaceutical development. Rather, it can be shown that still in the 1990s, linear processes of innovation and the close combination of practical and epistemic work were interdependent.|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Kristen Intemann & Inmaculada de Melo-Martín (2010). Social Values and Scientific Evidence: The Case of the HPV Vaccines. Biology and Philosophy 25 (2):203-213.
Don C. Des Jarlais, Paul A. Gaist & Samuel R. Friedman (1995). Ethical Issues in Research on Preventing HIV Infection Among Injecting Drug Users. Science and Engineering Ethics 1 (2):133-144.
Jayraj Jadeja, Bharat R. Shah & Preshth Bhardwaj (2005). Codes of Business Conduct. International Corporate Responsibility Series 2:359-374.
Henry Adobor (2012). Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry. [REVIEW] Journal of Business Ethics 105 (2):239-255.
Arrigo Schieppati, Norberto Perico & Giuseppe Remuzzi (2002). Conflict of Interest as Seen From a Researcher's Perspective. Science and Engineering Ethics 8 (3):337-342.
Harvey E. Bale (2005). Industry, Innovation and Social Values. Science and Engineering Ethics 11 (1).
Laurence J. Hirsch (2002). Conflicts of Interest in Drug Development: The Practices of Merck & Co., Inc. Science and Engineering Ethics 8 (3):429-442.
Matthias Adam, Multi-Level Complexities in Technological Development: Competing Strategies for Drug Discovery.
Added to index2009-01-28
Total downloads13 ( #95,562 of 731,463 )
Recent downloads (6 months)1 ( #61,087 of 731,463 )
How can I increase my downloads?